Microba (ASX:MAP) seals deal with nib-backed Midnight Health for Vidality

2 min read | May 26, 2022 12:08 PM AEST | By Aditi Sarkar

Google News:

Microba (ASX:MAP) seals deal with nib-backed Midnight Health for Vidality — Image source: © Ivelinr | Megapixl.com

Recent News

Can the ASX 200 Rise as Alphabet and Tesla Rattle Wall Street? (23 Jul...

Why Is (ASX:WDS) Powering a Stronger ASX Open?

Why Are Australian Shares Set to Rise While New Zealand Falls?

Why Could the ASX Defy Wall Street as Oil Prices Surge?

Make Kalkine Media
My Trusted Source

Highlights

Microba Life Sciences has partnered with Midnight Health to offer Vidality, a truly personalised solution powered by its technology.

nib Holdings-backed digital healthcare firm Midnight Health will be responsible for promoting, marketing, and selling Vidality.

Microba Life Sciences Limited (ASX:MAP) is all set to roll out a world-first subscription-based personalised consumer health service called Vidality.

In a significant development, the company joined hands with Midnight Health, a digital healthcare firm backed by nib Holdings Limited (ASX:NHF), concerning Vidality.

Microba is a precision microbiome company focused on the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services on a global basis. The company is committed to enhancing human health with world-leading technology for measuring the human gut microbiome.

Midnight Health has a patient-led digital platform through which the firm delivers innovative online healthcare solutions.

Do read: Two ASX healthcare stocks AHX & RHC expand business with new acquisitions

Vidality: Bringing science and personalisation to healthcare industry

The agreement has been signed after a successful pilot focused on testing the service model and product offering. The pilot further exhibited Microba’s scalable technology and potential to deliver evidence-based gut health solutions.

The partnership will aid in providing a tailored health service to the Australian consumer market.

The agreement, which is for an initial period of three years, underlies the following:

Data source: company update

The model will be delivered through trained and registered pharmacists. It will be a personalised, pharmacy-integrated service model, bringing a level of science and personalisation to an industry which generally provides one-size-fits-all solutions to its customers.

CEO of Midnight Health, Nic Blair, highlighted the strong demand for innovative online and personalised healthcare solutions. The firm already caters to over 13,000 subscribers across its existing brands with strong month-on-month growth. Many of its customers are looking for gut health solutions, Blair added.

Commenting on the partnership, Microba CEO, Dr Luke Reid, said:

“Consumers are seeking personalised, evidence-based solutions to support their gut health. Together with Midnight Health, we are excited to bring the Vidality product to consumers, a truly personalised solution powered by our technology”.

Also read: WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.